Four updates:
1. Surveillance: Nationwide, the percentage of laboratory specimens testing positive for COVID-19 decreased slightly. However, four of 10 HHS surveillance regions saw an increase in the percentage of positive specimens: the Midwest, Central, Mountain and New York/New Jersey/Puerto Rico regions. The remaining regions reported stable or decreasing percentages of specimens testing positive for COVID-19.
2. Mortality: About 6.4 percent of deaths nationwide were attributed to flu, pneumonia or COVID-19 in the week ending July 11, down from 8.1 percent a week prior. This percentage marked the 12th week of decline.
3. Hospitalizations: The cumulative hospitalization rate for all age groups increased to 113.6 hospitalizations per 100,000 population. Hospitalizations increased over the two-week period ending July 4, representing the first multiple-week increase since early April.
4. Outpatient activity: Emergency department and outpatient visits for symptoms related to COVID-19 remained below baseline nationwide. Seven regions saw an increase in visits for COVID-19-like symptoms, which may be due to changes in healthcare seeking behavior after the July Fourth holiday, the CDC said.
More articles on public health:
CDC restores missing COVID-19 data but will stop updating site as HHS steps in
Missed childhood vaccines could be bigger threat than COVID-19, WHO says
85 infants test positive for COVID-19 in Texas county
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
